The first official version of the European quality assurance scheme for breast cancer services is now available on the European Commission web hub.
Boston Scientific to buy back pain treatment company Relievant for $850M
Dive Brief: Boston Scientific reached an agreement to acquire neuromodulation company Relievant Medsystems for $850 million upfront, the companies announced on Tuesday. Sunnyvale, California-based Relievant